ALPS

ALPS Group Inc

0.3400

Oct 16 • 4:00 PM ET +0.0010 (0.29%)

Healthcare Biotechnology Malaysia Micro NASD

Peers: SPRO VRCA VTVT ACOG CNTB GALT IMUX IPHA KZIA AGEN

Index	-
Market Cap	56.58M
Enterprise Value	62.13M
Income	-2.73M
Sales	0.00M
Book/sh	-3.19
Cash/sh	0.00
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	Feb 13, 2023
Dividend Gr. 3/5Y	- -
Payout	-
Employees	89
IPO	Dec 23, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	157.17
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.04
Current Ratio	0.04
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-0.73
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -11.58%
Sales past 3/5Y	- -
EPS Y/Y TTM	-610.86%
Sales Y/Y TTM	-
EPS Q/Q	-1113.92%
Sales Q/Q	-
Earnings	Aug 07 BMO
EPS/Sales Surpr.	- -

Insider Own	70.90%
Insider Trans	0.00%
Inst Own	0.32%
Inst Trans	3.69%
ROA	-17.24%
ROE	-62.50%
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-10.31%
SMA50	-8.70%
SMA200	-52.19%
Trades

Shs Outstand	166.40M
Shs Float	48.43M
Short Float	0.26%
Short Ratio	2.10
Short Interest	0.13M
52W High	12.01 -97.17%
52W Low	0.23 48.31%
Volatility	3.77% 6.06%
ATR (14)	0.02
RSI (14)	33.67
Beta	-0.52
Rel Volume	0.42
Avg Volume	60.01K
Volume	25,412

Perf Week	-8.11%
Perf Month	-14.98%
Perf Quarter	-28.03%
Perf Half Y	-65.93%
Perf YTD	-60.89%
Perf Year	-97.73%
Perf 3Y	-96.84%
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	0.34
Price	0.34
Change %	0.29%

Aug-07-26 08:00AM	Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update (GlobeNewswire)
Jun-23-26 08:05AM	Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia (GlobeNewswire)
Jun-09-26 08:05AM	Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022 (GlobeNewswire)
May-19-26 04:05PM	Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire) -8.99% -11.36%
Apr-17-26 08:30AM	Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight (GlobeNewswire)
08:00AM	Loading…
Feb-23-26 08:00AM	Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol (GlobeNewswire)
Jan-30-26 08:00AM	Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy (GlobeNewswire)
Jan-08-26 08:00AM	Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer (GlobeNewswire)
Oct-31-25 08:00AM	Alps Announces Closing of Business Combination with Globalink Investment Inc. (GlobeNewswire) -14.67%

Alps Group, Inc. operates as a biotechnology company that integrates research and development, medical services, and wellness solutions. The company focuses on creating a fair healthcare ecosystem, to make advance predictive, preventive, and precision medicine accessible and affordable. The company is headquartered in Kuala Lumpur, Malaysia.

PhDSeng Kong Tham

ALPS

ALPS Group Inc

Upgrade your Finviz experience